CIK: 1304113 - Address: C/O Aclaris Therapeutics, Inc., 701 Lee Road, Suite 103, Wayne, PA 19087
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/5/24 16:58
3/1/24
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPowell Andrew Kenneth WilliamPADP.m181.2401510129D
1/14/19 14:25
1/11/19
LNDCLandec Corp caDEFdBevFoodCanned, Fruits, Veg, PreservePowell Andrew Kenneth WilliamCADP611.62011111D
5/17/18 19:34
5/16/18
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPowell Andrew Kenneth WilliamPADP1019.1201New1D
11/30/07 15:23
11/28/07
CGPICollagenex Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsPowell Andrew Kenneth WilliamPAOVP,G. CoP17.300054I
11/20/07 16:44
11/16/07
CGPICollagenex Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsPowell Andrew Kenneth WilliamPAOVP,G. CoP38.0100124D
11/13/07 16:01
11/8/07
CGPICollagenex Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsPowell Andrew Kenneth WilliamPAOVP,G. CoP48.470086M
5/24/07 15:36
5/22/07
CGPICollagenex Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsPowell Andrew Kenneth WilliamPAOVP,G. CoP210.480083I
6/27/05 13:44
6/10/05
CGPICollagenex Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsPowell Andrew Kenneth WilliamPAOVP,G. CoP.am94.8602754M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact